CDEK
← All organizations

Oncopeptides AB

For profitWebsite ↗

Also known as: Oncopeptides AB | ONCOPEPTIDES AB | Oncopeptides AB, Stockholm, Sweden

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jul 1, 2013

First marketed drug

Feb 26, 2021

Last known activity

May 27, 2021

Timeline

2000s

  1. Jun 1, 2000

    Oncopeptides AB— Founded

2020s

  1. Feb 26, 2021

    melphalan— Marketing Organization

  2. Feb 26, 2021

    melphalan— NDA Secondary Org

Drugs by trial phase (7 distinct, 10 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (11)

Details

Founded
Stockholm, SE Jun 1, 2000
Last known activity
May 27, 2021